Kiskinis lab work published in journal Cell Stem Cell

We are excited to share a newly published finding from Dr. Evangelos Kiskinis, one of the lead researchers at the Les Turner ALS Center at Northwestern Medicine. A few words from Dr. Kiskinis: “In our latest manuscript, which was published …

Machine learning: Calculating disease

“Machine learning might identify patients earlier, predict their outcomes better, and assign them more efficiently to appropriate clinical trials.” Read the full article highlighting machine learning in relation to ALS, on the Nature International Journal of Science, here. 

2018 Grants to Center

Your advocacy for advancements towards a cure allow us to continue innovative research in 2018. The Foundation will award over $1.1 million to the Center in 2018. This gift will fund six new research grants and continued support of the …

Cytokinetics Announces Negative Results from VITALITY-ALS

Cytokinetics announced the endpoints for the clinical trial of tirasemtiv (VITALITY-ALS) had not been met and that further development of the drug was being suspended. We share Cytokinetics, and your, disappointment in this announcement and are grateful for Cytokinetics continued …

Answer ALS Partnership

The Les Turner ALS Foundation is very pleased to announce the Les Turner ALS Research and Patient Center at Northwestern Medicine as the newest member of the single largest coordinated and collaborative effort to end ALS in the history of …

7th Annual Les Turner Symposium on ALS and NeuroRepair

The 7th Annual Les Turner Symposium on ALS and NeuroRepair will held on Monday, November 6 at Prentice Women’s Hospital. Celebrating research, patient care and education–attendees will get the opportunity to learn the latest on ALS drug development. Christopher Henderson, …

Radicava is Now Available for Treatment in U.S

Mitsubishi Tanabe Pharma America, Inc., today announced RADICAVA ™ (edaravone), an intravenous therapy indicated for all adult patients diagnosed with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is now available for treatment in the United States. RADICAVA, …

Collaboration in Research

A recent publication in Neurology Today highlights the research of Dr. Sabrina Paganoni who is testing a drug to slow the progression of ALS. This study is being done in collaboration with Les Turner ALS Research and Patient Center at Northwestern Medicine …